Fennec Pharmaceuticals GAAP EPS of -$0.17 misses by $0.21, revenue of $13.78M misses by $0.95M
Source: SeekingAlpha
2026-03-24 07:29:57 ET
More on Fennec Pharmaceuticals
- Seeking Alpha’s Quant Rating on Fennec Pharmaceuticals
- Historical earnings data for Fennec Pharmaceuticals
- Financial information for Fennec Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Fennec Pharmaceuticals GAAP EPS of -$0.17 misses by $0.21, revenue of $13.78M misses by $0.95M
Fennec Pharmaceuticals Inc.
NASDAQ: FRX:CC
FRX:CC Trading
0.23% G/L:
$8.69 Last:
300 Volume:
$8.67 Open:
FRX:CC Latest News
May 21, 2026 06:01:27 pm
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
May 14, 2026 06:30:00 am
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
May 07, 2026 06:36:00 am
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
April 21, 2026 04:30:00 pm
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
